PFREUNDSCHUH PETER P. has filed 15 insider transactions across 2 companies since February 2023.
Most recent transaction: a disposition of 63500 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on September 16, 2025.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | EVP, CFO and Treasurer | D | Employee Stock Option (right to buy) | 63500 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.14% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | EVP, CFO and Treasurer | D | Restricted Stock Units | 15900 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.04% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | EVP, CFO and Treasurer | D | Restricted Stock Units | 15900 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.04% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | EVP, CFO and Treasurer | D | Common Stock | 77800 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.17% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | EVP, CFO and Treasurer | D | Employee Stock Option (right to buy) | 170000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.38% |
| Jan. 17, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | CFO and Treasurer | A | Common Stock | 31800 | $0.00 | 77,800.0000 | 44,328,962 | 69.13% | 0.07% |
| Jan. 17, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | CFO and Treasurer | A | Employee Stock Option (right to buy) | 63500 | $0.00 | 63,500.0000 | 44,328,962 | 9999.99% | 0.14% |
| July 12, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | CFO and Treasurer | A | Common Stock | 46000 | $0.00 | 46,000.0000 | 44,022,356 | 9999.99% | 0.10% |
| July 12, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | PFREUNDSCHUH PETER P. | CFO and Treasurer | A | Employee Stock Option (right to buy) | 170000 | $0.00 | 170,000.0000 | 44,022,356 | 9999.99% | 0.39% |
| Feb. 21, 2024 | Voyager Therapeutics, Inc. | $VYGR | PFREUNDSCHUH PETER P. | Chief Financial Officer | S | Common Stock | 3764 | $7.46 | 175,669.0000 | 44,569,334 | 2.10% | 0.01% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | PFREUNDSCHUH PETER P. | Chief Financial Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 44,569,334 | 9999.99% | 0.13% |
| Feb. 9, 2024 | Voyager Therapeutics, Inc. | $VYGR | PFREUNDSCHUH PETER P. | Chief Financial Officer | A | Common Stock | 30000 | $0.00 | 179,433.0000 | 44,569,334 | 20.08% | 0.07% |
| Oct. 3, 2023 | Voyager Therapeutics, Inc. | $VYGR | PFREUNDSCHUH PETER P. | Chief Financial Officer | S | Common Stock | 13567 | $6.99 | 149,433.0000 | 43,864,838 | 8.32% | 0.03% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | PFREUNDSCHUH PETER P. | Chief Financial Officer | A | Common Stock | 38000 | $0.00 | 163,000.0000 | 38,356,810 | 30.40% | 0.10% |
| Feb. 17, 2023 | Voyager Therapeutics, Inc. | $VYGR | PFREUNDSCHUH PETER P. | Chief Financial Officer | A | Stock Option (Right to Buy) | 76000 | $0.00 | 76,000.0000 | 38,356,810 | 9999.99% | 0.20% |